Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial.

@article{Tamez2017EffectOS,
  title={Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial.},
  author={Hector Tamez and Duane S Pinto and Ajay J. Kirtane and Claire Litherland and Robert W Yeh and George D Dangas and Roxana Mehran and Efthymios N. Deliargyris and Guillermo A Ortiz and C Michael Gibson and Gregg Whitney Stone},
  journal={JAMA cardiology},
  year={2017},
  volume={2 6},
  pages={673-677}
}
Importance Bivalirudin has been associated with reduced bleeding and mortality during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI). However, increased rates of acute stent thrombosis (AST) have been noted when bivalirudin is discontinued at the end of the procedure, which is perhaps related to this… CONTINUE READING